HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $156,000 | +178.6% | 3,553 | +153.4% | 0.01% | +200.0% |
| Q4 2021 | $56,000 | +21.7% | 1,402 | +24.4% | 0.00% | +100.0% |
| Q3 2021 | $46,000 | -42.5% | 1,127 | -36.1% | 0.00% | -66.7% |
| Q2 2021 | $80,000 | -12.1% | 1,765 | -17.2% | 0.00% | -25.0% |
| Q4 2020 | $91,000 | -33.1% | 2,131 | -58.1% | 0.00% | -73.3% |
| Q2 2020 | $136,000 | +518.2% | 5,083 | +310.6% | 0.02% | +50.0% |
| Q1 2020 | $22,000 | -60.7% | 1,238 | -60.8% | 0.01% | -23.1% |
| Q4 2019 | $56,000 | +5500.0% | 3,161 | +5978.8% | 0.01% | – |
| Q3 2018 | $1,000 | 0.0% | 52 | +67.7% | 0.00% | -100.0% |
| Q1 2018 | $1,000 | 0.0% | 31 | -78.6% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | -98.8% | 145 | -97.9% | 0.00% | -97.8% |
| Q3 2016 | $82,000 | – | 6,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |